Dima Kuzmin, Ph.D. is the co-founder and managing partner of 4BIO Capital in London, UK, and a scientific co-founder and the board chair of NV Therapeutics.

Dima has led the 4BIO Capital effort to promote the advanced therapies field as an early-stage investor and adviser to newly forming companies. He leads the technical team at 4BIO and has served on the boards of several biotech companies, including RetroSense Therapeutics, RedPin Therapeutics, Vespula Therapeutics, Hornet Therapeutics, Ray Therapeutics, Trogenix and Araris Biotech. Prior to founding 4BIO, he trained as a neuroscientist serving as a Doctoral Fellow in neurobiology at the Max Planck Institute for Brain Research and a Research Fellow in optogenetics and gene therapy for CNS disease at the University College London Institute of Neurology. He serves as an Assistant Professor of Medicine (Adjunct) at Yale University School of Medicine, and is a Fellow of the Royal Society of Medicine and of the Royal Society of Biology.